Cognitive impairment is more common and severe in older adults with MS than in younger patients, but this is driven by ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results